UCB

UCB.BR | EURONEXT | 0 Urmăritori

€170.80

-1.04%

-€1.80

Urmărește

Overview Metrics Financials

Fair Price

GPR786.22

Undervalued by 9.7%

Pentru a afișa prețul corect al unei acțiuni, trebuie să fiți membru Bulios Black.

Profile

UCB SA (UCB) is a biopharmaceutical company based in Belgium, focusing on research, development, and production of medicinal products for the treatment of neurological and immunological disorders. The company specializes in medications for conditions such as epilepsy, Parkinson's disease, multiple sclerosis, and rheumatoid arthritis, among others. Their portfolio includes innovative drugs, biologic products, and prescription medications that improve the quality of life for patients suffering from these conditions. UCB also invests in research and development of new medications to provide effective and safe therapeutic options for patients worldwide. UCB SA (UCB) shares may be attractive to investors seeking investments in biopharmaceutical companies with an emphasis on innovation and treatment of neurological and immunological disorders.

Feed

There are no posts to show right now.

UCB

Fair Price

Profile

Feed

Logare în Bulios

Creează-ți profilul pe Bulios

De ce Bulios?